[Federal Register Volume 88, Number 204 (Tuesday, October 24, 2023)]
[Notices]
[Page 73020]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2023-23460]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Centers for Disease Control and Prevention


Board of Scientific Counselors, Deputy Director for Infectious 
Diseases

AGENCY: Centers for Disease Control and Prevention (CDC), Department of 
Health and Human Services (HHS).

ACTION: Notice of meeting.

-----------------------------------------------------------------------

SUMMARY: In accordance with regulatory provisions, the Centers for 
Disease Control and Prevention (CDC) announces the following meeting of 
the Board of Scientific Counselors, Deputy Director for Infectious 
Diseases (BSC, DDID). This virtual meeting is open to the public via 
Zoom, limited only by the number of web conference lines available (500 
lines). Registration in advance is required by accessing the link below 
in the addresses section. Time will be available for public comment.

DATES: The meeting will be held on November 30, 2023, from 1:30 p.m. to 
3 p.m., EST.

ADDRESSES: Zoom virtual meeting. Registration in advance is required by 
accessing the link at https://cdc.zoomgov.com/webinar/register/WN__r2EU3xBTB6MBiQq_HdqNQ. Instructions to access the meeting will be 
provided following registration.

FOR FURTHER INFORMATION CONTACT: Sarah Wiley, MPH, Senior Advisor, 
National Center for Emerging and Zoonotic Infectious Diseases, Centers 
for Disease Control and Prevention, 1600 Clifton Road NE, Mailstop H16-
5, Atlanta, Georgia 30329-4037. Telephone: (404) 639-4840; Email: 
<a href="/cdn-cgi/l/email-protection#3261655b5e574b725156511c555d44"><span class="__cf_email__" data-cfemail="5b080c32373e221b383f38753c342d">[email protected]</span></a>.

SUPPLEMENTARY INFORMATION: Purpose: The Board of Scientific Counselors, 
Deputy Director for Infectious Diseases (BSC, DDID) provides advice and 
guidance to the Secretary, Department of Health and Human Services; the 
Director, Centers for Disease Control and Prevention (CDC); and the 
Directors of the National Center for Emerging and Zoonotic Infectious 
Diseases, the National Center for HIV, Viral Hepatitis, STD, and TB 
Prevention, the National Center for Immunization and Respiratory 
Diseases, concerning strategies, goals, and priorities for the programs 
and research within the national centers and monitors the overall 
strategic direction and focus of CDC's infectious disease programs and 
centers.
    Matters To Be Considered: The agenda will include updates and 
discussions on recent outbreaks and disease surveillance strategies, as 
well as a brief report from one of the Board's workgroups: the Food 
Safety Modernization Act Surveillance Working Group. Agenda items are 
subject to change as priorities dictate.
    The Director, Office of Strategic Business Initiatives, Office of 
the Chief Operating Officer, Centers for Disease Control and 
Prevention, has been delegated the authority to sign Federal Register 
notices pertaining to announcements of meetings and other committee 
management activities, for both the Centers for Disease Control and 
Prevention and the Agency for Toxic Substances and Disease Registry.

Kalwant Smagh,
Director, Office of Strategic Business Initiatives, Office of the Chief 
Operating Officer, Centers for Disease Control and Prevention.
[FR Doc. 2023-23460 Filed 10-23-23; 8:45 am]
BILLING CODE 4163-18-P


</pre><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script></body>
</html>